Ascendis Pharma
ASND
ASND
279 hedge funds and large institutions have $12.7B invested in Ascendis Pharma in 2025 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 99 increasing their positions, 92 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more funds holding in top 10
Funds holding in top 10: 16 → 17 (+1)
8% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 92
0.65% more ownership
Funds ownership: 102.88% → 103.53% (+0.65%)
Holders
279
Holding in Top 10
17
Calls
$124M
Puts
$39.3M
Top Buyers
| 1 | +$164M | |
| 2 | +$143M | |
| 3 | +$74.6M | |
| 4 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$72.5M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$36M |
Top Sellers
| 1 | -$171M | |
| 2 | -$104M | |
| 3 | -$79.3M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$50.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$37.9M |
